STAT3 and colonic neoplasm: Supporting this hypothesis, high STAT3 activity in CAFs correlates with poor patient prognosis in colorectal cancer and inactivation of STAT3 reduces tumor burden in a murine model of inflammation-associated colon cancer (43).